OXBT.COM

Oxford BioTherapeutics

Oxford BioTherapeutics is an international biotechnology company focused on developing innovative antibody drug conjugates (ADCs) to treat cancer. This new treatment approach combines a number of technologies to target cancer cells with potent cell-killing agents. Our OGAP target discovery system - the largest of its type in the world - 'unlocks' the power of ADCs by providing a unique range of validated, novel targets identified from a wide range of cancer types.

http://www.oxbt.com/

OVERVIEW OF oxbt.com

TRAFFIC RANK

>1,000,000

REVIEWS

0

PAGES IN THIS WEBSITE

3

LINKS TO THIS WEBSITE

CONTACTS

ADDRESSES

SOCIAL LINKS

ONLINE SINCE

WEBSITE DETAILS

SEO

PAGES

SIMILAR SITES

TRAFFIC RANK FOR OXBT.COM

TODAY'S RATING

>1,000,000

TRAFFIC RANK - AVERAGE PER MONTH

BEST MONTH

November

AVERAGE PER DAY Of THE WEEK

HIGHEST TRAFFIC ON

Tuesday

TRAFFIC BY CITY

Sign up

CUSTOMER REVIEWS

Average Rating: 3.9 out of 5 with 17 reviews

5 star

8

4 star

3

3 star

4

2 star

0

1 star

2

Hey there! Start your review of oxbt.com

AVERAGE USER RATING

Write a Review

WEBSITE PREVIEW

LOAD TIME

CONTACTS AT OXBT.COM

OXFORD BIOTHERAPEUTICS

94A M●●●●● Park

Abi●●●don , OX14 4RY

GB

View this contact

Namesco Limited

Domain Administrator

Acton Hou●●●●●●●●●well Park

Wor●●●ter , WR3 7GD

GB

44 84●●●●●33630

tr●●●●●●●●●●●●@names.co.uk

View this contact

Namesco Limited

Namesco Limited

Acton Hou●●●●●●●●●well Park

Wor●●●ter , WR3 7GD

GB

44 84●●●●●33630

44 84●●●●● 3631

re●●●●●●●●●@names.co.uk

View this contact

ADD CONTACT

Login

TO VIEW CONTACTS

Remove Contacts

FOR PRIVACY ISSUES

DOMAIN REGISTRATION INFORMATION

REGISTERED: 2005 July 04
UPDATED: 2013 June 13
EXPIRATION: EXPIRED REGISTER THIS DOMAIN

BUY YOUR DOMAIN

DOMAIN AGE

20

YEARS
4

MONTHS
0

DAYS

NAME SERVERS

1: ns0.phase8.net
2: ns1.phase8.net
3: ns2.phase8.net

REGISTRAR

REGISTER.IT SPA

WHOIS : whois.register.it

REFERRED : http://we.register.it

CONTENT

PAGES IN
THIS WEBSITE

3

SSL

EXTERNAL LINKS

0

SITE IP

85.233.160.22

LOAD TIME

0 sec

SCORE

6.2

PAGE TITLE

Oxford BioTherapeutics | oxbt.com Reviews

<META> DESCRIPTION

Oxford BioTherapeutics is an international biotechnology company focused on developing innovative antibody drug conjugates (ADCs) to treat cancer. This new treatment approach combines a number of technologies to target cancer cells with potent cell-killing agents. Our OGAP target discovery system - the largest of its type in the world - 'unlocks' the power of ADCs by providing a unique range of validated, novel targets identified from a wide range of cancer types.

<META> KEYWORDS

1 about us

2 management

3 board of directors

4 investors

5 careers uk

6 careers usa

7 technologies

8 antibody development

9 cancer therapy development

10 pipeline

CONTENT

Page content here

KEYWORDS ON PAGE

about us,management,board of directors,investors,careers uk,careers usa,technologies,antibody development,cancer therapy development,pipeline,lead programs,news,press releases,news archives,precision,cancer,therapy,latest news,global headquarters,sitemap

SERVER

Apache

CONTENT-TYPE

utf-8

GOOGLE PREVIEW

Oxford BioTherapeutics | oxbt.com Reviews

https://oxbt.com

Oxford BioTherapeutics is an international biotechnology company focused on developing innovative antibody drug conjugates (ADCs) to treat cancer. This new treatment approach combines a number of technologies to target cancer cells with potent cell-killing agents. Our OGAP target discovery system - the largest of its type in the world - 'unlocks' the power of ADCs by providing a unique range of validated, novel targets identified from a wide range of cancer types.

INTERNAL PAGES

oxbt.com

1

Oxford BioTherapeutics | News

http://www.oxbt.com/news

OGAP – Cancer Targeting. Antibody ‘arming’. Oxford BioTherapeutics provides regular updates of our R&D, scientific and corporate progress through regular conference presentations, scientific journal publications and press releases. For more information please contact us. The OBT / Menarini partnership has been cited in the September issue of Nature’s BioPharma Dealmakers as the second most significant antibody and ADC technology platform deals over $100m total deal value between Jan 2009 July 2014. Oxfor...

2

Oxford BioTherapeutics | Pipeline

http://www.oxbt.com/pipeline

OGAP – Cancer Targeting. Antibody ‘arming’. Strong portfolio of novel antibody-based cancer therapies. Oxford BioTherapeutics is focused on developing innovative antibody-based cancer treatments, based on a range of proprietary technologies. OBT357/MEN1112 – AML. OX002/MEN1309 – TNBC. OX003 – SCLC / NSCLC. AML = acute myeloid leukemia. TNBC = triple negative breast cancer. SCLC = small cell lung cancer. NSCLC = non-small cell lung cancer. 44 (0) 1235 861770. San Jose, CA 95138.

3

Oxford BioTherapeutics | About Us

http://www.oxbt.com/about-us

OGAP – Cancer Targeting. Antibody ‘arming’. Through our collaborations with other leading companies in the field, such as Seattle Genetics, ImmunoGen, Medarex and Amgen, we can use the optimal combination of technologies to develop successful ADCs. First in-house clinical candidate designated. Collaboration with Boehringer Ingelheim. 1BN R&D investment collaboration with Menarini. Cancer toxin collaboration with Seattle Genetics. Enhanced antibody partnership with BioWa. Antibody partnership with Amgen.

UPGRADE TO PREMIUM TO VIEW 0 MORE

TOTAL PAGES IN THIS WEBSITE

3

OTHER SITES

oxbspeaking.com

옥스비스피킹 홈페이지에 오신 여러분을 환영합니다

대표이사 양동인 ㅣ 서울특별시 강남구 테헤란로5길 11 옥스비 에듀타운 ㅣ 사업자등록번호 220-87-35161. 통신판매업신고번호 2008-서울강남-2843호 ㅣ 대표전화 1566-0511 ㅣ FAX 02)6217-0515.

oxbsscholarship.com

Theta Chi Scholarship

Theta Chi Beta Sigma. Hello and welcome to the Theta Chi Beta Sigma Scholarship Website. This website has been designed to streamline Theta Chi scholarship. Simply log in to the website and log any hours that you have spent studying in the library, in your room, or anywhere else on campus. In addition to this, you may view the amount of hours you have submitted over the course of the entire semester, and on a week to week basis. If you are a brother of Beta Sigma, then click on this link.

oxbstudio.com

oxbstudio-architecture

OXBSTUDIO is a multi-disciplinary architectural firm specializing in high-end custom residential projects. We look to develop a unique method of design for each client, whose desires, needs, beliefs and building sites are different from any other. We balance the client’s requirements with functionality, constructibility and the use of diverse materials to create spaces and forms which are stimulating, distinctive and appropriate. C) 2015 - Artcore Creative Architecture WordPress Theme.

oxbsz.leteya.pw

leteya.pw

oxbt.co.uk

Oxford BioTherapeutics

OGAP – Cancer Targeting. Antibody ‘arming’. Our novel cancer therapies combine a number of precision technologies. We are focused on developing antibody-drug conjugates to treat a range of cancers. Our antibody-based therapeutics target a variety of difficult to treat cancers. Targeting Unmet Needs in Cancer with Antibody-Drug Conjugates. Targeting Unmet Needs in Cancer with Antibody-Drug Conjugates. We are developing precision cancer therapies. Our therapies incorporate leading technologies. Oxford BioT...

oxbt.com

Oxford BioTherapeutics

OGAP – Cancer Targeting. Antibody ‘arming’. Our novel cancer therapies combine a number of precision technologies. We are focused on developing antibody-drug conjugates to treat a range of cancers. Our antibody-based therapeutics target a variety of difficult to treat cancers. Targeting Unmet Needs in Cancer with Antibody-Drug Conjugates. Targeting Unmet Needs in Cancer with Antibody-Drug Conjugates. We are developing precision cancer therapies. Our therapies incorporate leading technologies. Oxford BioT...

oxbtc.com

牛比特-OXBTC

oxbtest.com

TEST CENTER - 영어 테스트 전문. 옥스비어학원

TOEFL / 아카데믹 라이팅 / 개인 레슨] 7월 수업. 주말 집중회화 7월 수강신청 안내]. 소수 정원 TOEFL] 7월 수업 안내. 아카데믹 라이팅 7월 특강 안내]. 아카데믹 라이팅] 7월 수업 공지 안내. 토, 일 주말 집중 영어회화] 6월 개강 안내. 소수정원 토플] 6월 수업 공지. 소수정원 TOEFL] 5월 수업 안내. 토,일 주말집중 영어회화] 5월 개강 안내.

oxbtoeic.com

?щщ?? 諛⑸Ц? ???⑸??

oxbu.com

domain for sale

oxbucks.com

Home

EqualLogic Introduces Preferred VMware Partner Program. EqualLogic leverages VMware expertise to provide customers with turnkey virtual infrastructure solutions. EqualLogic presents The Future of iSCSI SANs, featuring Gartner. View the 10-minute webcast. EqualLogic Introduces Data Segmentation and Pooling. PS Series Version 3.0 firmware delivers more choice and control to storage managers by enabling flexible data segmentation with multiple pools of storage in a single SAN. Winner of Excellence in iSCSI.